JP2000506128A5 - - Google Patents

Download PDF

Info

Publication number
JP2000506128A5
JP2000506128A5 JP1997529954A JP52995497A JP2000506128A5 JP 2000506128 A5 JP2000506128 A5 JP 2000506128A5 JP 1997529954 A JP1997529954 A JP 1997529954A JP 52995497 A JP52995497 A JP 52995497A JP 2000506128 A5 JP2000506128 A5 JP 2000506128A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1997529954A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000506128A (ja
Filing date
Publication date
Priority claimed from IL11722396A external-priority patent/IL117223A0/xx
Application filed filed Critical
Publication of JP2000506128A publication Critical patent/JP2000506128A/ja
Publication of JP2000506128A5 publication Critical patent/JP2000506128A5/ja
Ceased legal-status Critical Current

Links

JP9529954A 1996-02-22 1997-02-20 抗病原性ペプチドおよびこれらを含む組成物 Ceased JP2000506128A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL117223 1996-02-22
IL11722396A IL117223A0 (en) 1996-02-22 1996-02-22 Antipathogenic polypeptides and compositions comprising them
PCT/IL1997/000066 WO1997031019A2 (en) 1996-02-22 1997-02-20 Antipathogenic peptides and compositions comprising them

Publications (2)

Publication Number Publication Date
JP2000506128A JP2000506128A (ja) 2000-05-23
JP2000506128A5 true JP2000506128A5 (enExample) 2004-11-11

Family

ID=11068576

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9529954A Ceased JP2000506128A (ja) 1996-02-22 1997-02-20 抗病原性ペプチドおよびこれらを含む組成物

Country Status (13)

Country Link
US (1) US6172038B1 (enExample)
EP (1) EP0904291A2 (enExample)
JP (1) JP2000506128A (enExample)
KR (2) KR19990087100A (enExample)
CN (1) CN1216549A (enExample)
AU (1) AU730069B2 (enExample)
BR (1) BR9707691A (enExample)
CA (1) CA2247025A1 (enExample)
CZ (1) CZ264398A3 (enExample)
EA (1) EA199800754A1 (enExample)
IL (2) IL117223A0 (enExample)
NZ (1) NZ331219A (enExample)
WO (1) WO1997031019A2 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9807456A (pt) * 1997-02-20 2000-04-25 Yeda Res & Dev Peptìdios antipatogênicos sintéticos e composições que compreendem os mesmos
BR9912053A (pt) 1998-07-13 2001-04-03 Univ Texas Processos de tratamento de câncer utilizando conjugados terapêuticos que se ligam a aminofosfolipìdios
US6818213B1 (en) 1998-07-13 2004-11-16 Board Of Regents, The University Of Texas System Cancer treatment compositions comprising therapeutic conjugates that bind to aminophospholipids
US7488590B2 (en) 1998-10-23 2009-02-10 Amgen Inc. Modified peptides as therapeutic agents
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
ATE348163T1 (de) 1998-10-23 2007-01-15 Amgen Inc Thrombopoietin substitute
GB0005703D0 (en) 2000-03-09 2000-05-03 Alpharma As Compounds
IL139720A0 (en) * 2000-11-16 2002-02-10 Yeda Res & Dev Diastereomeric peptides and pharmaceutical compositions comprising them
US7671011B2 (en) * 2003-06-19 2010-03-02 Yeda Research & Development Co. Ltd. Antimicrobial and anticancer lipopeptides
EP1773400A2 (en) 2004-07-08 2007-04-18 Amgen Inc. Therapeutic peptides
CA2580796C (en) 2004-09-24 2013-03-26 Amgen Inc. Modified fc molecules having peptides inserted in internal loop regions
CN101291683B (zh) * 2004-11-24 2011-08-17 纽普罗研究有限公司 治疗疾病的方法和组合物
WO2006128289A1 (en) * 2005-06-02 2006-12-07 University Of Manitoba Use of brevinin-2r in the treatment of cancer
US8008453B2 (en) 2005-08-12 2011-08-30 Amgen Inc. Modified Fc molecules
EP1973556A2 (en) * 2005-12-27 2008-10-01 Yeda Research And Development Co., Ltd. Histidine-containing diastereomeric peptides and uses thereof
JP2009526046A (ja) 2006-02-10 2009-07-16 デルマゲン アクティエボラーグ 新規分子
US9283260B2 (en) 2006-04-21 2016-03-15 Amgen Inc. Lyophilized therapeutic peptibody formulations
WO2014038004A1 (ja) * 2012-09-05 2014-03-13 株式会社メニコン 薬物徐放性眼用レンズ及びその製造方法
JP6093528B2 (ja) * 2012-09-19 2017-03-08 株式会社ミルボン スクリーニング方法
WO2017134661A1 (en) 2016-02-04 2017-08-10 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Methods for disrupting biofilms
GB2557654A (en) * 2016-12-14 2018-06-27 Uea Enterprises Ltd Method for nucleic acid depletion
CN113528600A (zh) * 2021-07-08 2021-10-22 石河子大学 一种利用沙门氏菌诱导蝇蛆制备抗菌肽的方法
CN119607173B (zh) * 2025-01-07 2026-05-26 天津医科大学朱宪彝纪念医院(天津医科大学代谢病医院、天津代谢病防治中心) 小分子肽lklkll在制备降血糖产品中的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5258454A (en) * 1988-09-01 1993-11-02 Riso National Laboratory Peptide synthesis method and solid support for use in the method

Similar Documents

Publication Publication Date Title
JP2000507118A5 (enExample)
JP2000507029A5 (enExample)
JP2001511216A5 (enExample)
JP2000503557A5 (enExample)
JP2000504949A5 (enExample)
JP2000503235A5 (enExample)
JP2000511898A5 (enExample)
JP2000506650A5 (enExample)
JP2000504992A5 (enExample)
JP2000504267A5 (enExample)
JP2000506724A5 (enExample)
JP2001501714A5 (enExample)
JP2000503617A5 (enExample)
JP2000501774A5 (enExample)
JP2000506134A5 (enExample)
JP2000507133A5 (enExample)
JP2001511765A5 (enExample)
JP2000505356A5 (enExample)
JP2000506326A5 (enExample)
JP2000503321A5 (enExample)
JP2000504045A5 (enExample)
JP2000503984A5 (enExample)
JP2000500857A5 (enExample)
JP2000510978A5 (enExample)
JP2001502744A5 (enExample)